Meridian Bioscience (VIVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 71,407 | 64,750 | 53,081 | 26,779 | 46,186 |
| Depreciation Amortization | 15,286 | 11,182 | 7,435 | 3,729 | 13,567 |
| Income taxes - deferred | -3,835 | -35 | -777 | -852 | 760 |
| Accounts receivable | -12,766 | -2,363 | -5,267 | -1,776 | -971 |
| Accounts payable and accrued liabilities | 6,346 | -2,252 | 77 | -5,826 | 7,248 |
| Other Working Capital | -19,240 | -21,176 | -18,597 | -6,823 | -10,046 |
| Other Operating Activity | 9,667 | 2,280 | 5,539 | 9,890 | -8,768 |
| Operating Cash Flow | $66,865 | $52,386 | $41,491 | $25,121 | $47,976 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -18,312 | -16,407 | -11,955 | -2,086 | -3,299 |
| Net Acquisitions | -18,585 | N/A | N/A | -5,000 | -51,299 |
| Other Investing Activity | -3,500 | -5,000 | -5,000 | 0 | 0 |
| Investing Cash Flow | $-40,397 | $-21,407 | $-16,955 | $-7,086 | $-54,598 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 10,000 | N/A | N/A | N/A | 50,000 |
| Common Stock Issued | 3,052 | 2,939 | 2,852 | N/A | 3,559 |
| Other Financing Activity | -44,121 | -18,824 | -18,824 | -10,000 | -57,116 |
| Financing Cash Flow | $-31,069 | $-15,885 | $-15,972 | $-10,000 | $-3,557 |
| Exchange Rate Effect | 858 | 1,404 | 1,296 | 1,644 | 1,296 |
| Beginning Cash Position | 53,514 | 53,514 | 53,514 | 53,514 | 62,397 |
| End Cash Position | 49,771 | 70,012 | 63,374 | 63,193 | 53,514 |
| Net Cash Flow | $-3,743 | $16,498 | $9,860 | $9,679 | $-8,883 |
| Free Cash Flow | |||||
| Operating Cash Flow | 66,865 | 52,386 | 41,491 | 25,121 | 47,976 |
| Capital Expenditure | -18,312 | -16,407 | -11,955 | -2,086 | -3,299 |
| Free Cash Flow | 48,553 | 35,979 | 29,536 | 23,035 | 44,677 |